Clinical issues:

With the continuous increase in the number of patients with peripheral neuropathy, there is an increasingly urgent need for early, accurate, and quantifiable sensory nerve function assessment in clinical practice. Traditional nerve conduction testing (NCS) has certain limitations in evaluating small fiber neuropathy and early functional abnormalities. The sensory nerve induction detector based on international standard quantitative sensory testing (QST) technology provides a new and accurate evaluation tool for the diagnosis and treatment of peripheral neuropathy and chronic pain.

Core functions:

Applicable departments and indications

1. Neurology

• Diabetes peripheral neuropathy (DPN)
• Small fiber neuropathy (SFN)
• Chronic pain (such as fibromyalgia, neuropathic pain)

2. Endocrinology Department

• Screening and management of diabetes neuropathy
• Assessment of metabolic disease-related neurological damage

3. Pain department/Rehabilitation department

• Diagnosis of neuropathic pain (such as PHN, CRPS)
• Postoperative monitoring of neurological function recovery

4. Research field

• Clinical trials of new drugs (such as analgesics, neurotrophic agents)
• Research on neurodegenerative diseases

QST vs. Traditional Neuroelectrophysiological Testing